Laxmi Organic Industries Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
LXCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Laxmi Organic Industries has filed its quarterly compliance statement under SEBI's Regulation 32, confirming that there has been no deviation or variation in how it has used the Rs. 2,591.21 million it raised through a Qualified Institutional Placement (QIP) in October 2023. The funds were earmarked for four purposes: setting up a new innovation centre at Mahape (Rs. 360.01 Mn), a new manufacturing facility at Dahej in Gujarat (Rs. 1,619.66 Mn), general corporate purposes (Rs. 506.05 Mn), and offer-related expenses (Rs. 105.49 Mn). A small saving of Rs. 5.08 million in issue expenses was redirected to the general corporate purposes bucket, slightly increasing it from Rs. 500.97 Mn to Rs. 506.05 Mn. India Ratings & Research is acting as the monitoring agency, and the audit committee has reviewed the statement with no adverse comments from auditors.
This is a routine regulatory compliance filing with no negative implications — it simply confirms the company has stuck to its stated plan for deploying the QIP money. Shareholders can take it as a mild positive signal of fund-utilisation discipline, though it is unlikely to move the stock price on its own.